AMMECR1L

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, AMMECR1L mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated AMMECR1L data layer compared with 26 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher AMMECR1L mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated AMMECR1L expression acts as an unfavorable survival marker.

LSCC are the cancer types where AMMECR1L mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
LSCCOSQuartileII,III,IV0.4891.000.0232view →
Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

AMMECR1L–LSCC (OS)

Kaplan–Meier survival curve for AMMECR1L mass-spec protein-high vs -low samples in LSCC.

Open the LSCC breakdown →

Exploration